Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

Condition(s) studied

Investigational drug(s) / intervention(s)

Lipid panel: Lipid panel measuring levels of LDL, non-HDL and apoB

Study summary

Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization.

It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute.

Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission.

Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.

Eligibility

Primary outcome measure(s)

• Variation in LDL — Day 0 to day 2
  Evaluation of the variation in LDL levels during a hospital admission for myocardial infarction

Trial sites (2)

More Montreal Heart Institute trials in Canada

Other trials for the same condition